Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810783 · ClinicalTrials.gov registry record · Phase 3
Brexpiprazole in Patients With Schizophrenia
A Phase 3 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 210
- Enrollment target
NCT01810783 is a Phase 3 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 210 participants.
The verdict
NCT01810783, a Phase 3 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 210 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of brexpiprazole during long-term treatment.
Interventions
- DRUG Brexpiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810783
The ClinicalTrials.gov registry entry for NCT01810783 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brexpiprazole is the first listed.
NCT01810783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810783 about?
NCT01810783 is a clinical study titled "Brexpiprazole in Patients With Schizophrenia". To determine the safety and efficacy of brexpiprazole during long-term treatment.
What is the current status of trial NCT01810783?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 210 participants. The study started on 2013-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01810783?
The interventions under investigation include: Brexpiprazole (DRUG).
Who is sponsoring clinical trial NCT01810783?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.